WEKO3
Item
Low dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis
https://jair.repo.nii.ac.jp/records/2002666
https://jair.repo.nii.ac.jp/records/200266639bb24bb-5b9c-41bd-9cb9-7d8c2f2d064d
| Name / File | License | Actions |
|---|---|---|
審査結果の要旨 (215.7 KB)
|
|
|
|
論文内容の要旨 (139.4 KB)
|
|
|
|
全文【著者最終稿】 (5.3 MB)
|
|
| Item type | 学位論文 / Thesis or Dissertation(1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PubDate | 2021-03-20 | |||||||||
| Title | ||||||||||
| Title | Low dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis | |||||||||
| Language | en | |||||||||
| Title | ||||||||||
| Alternative Title | (低用量mepolizumabは好酸球性多発血管炎性肉芽腫症患者の長期持続する末梢神経障害に対して有効である) | |||||||||
| Language | ja | |||||||||
| Language | ||||||||||
| Language | eng | |||||||||
| Resource Type | ||||||||||
| Resource Type Identifier | http://purl.org/coar/resource_type/c_db06 | |||||||||
| Resource Type | doctoral thesis | |||||||||
| Access Right | ||||||||||
| Access Rights | open access | |||||||||
| Access Rights URI | http://purl.org/coar/access_right/c_abf2 | |||||||||
| Creator |
中村, 祐人
× 中村, 祐人
|
|||||||||
| Degree Name | ||||||||||
| Language | ja | |||||||||
| Degree Name | 博士（医学） | |||||||||
| Degree Awarding Institution | ||||||||||
| Degree Grantor Name Identifier Scheme | kakenhi | |||||||||
| Degree Grantor Name Identifier | 32620 | |||||||||
| Language | ja | |||||||||
| Degree Grantor Name | 順天堂大学 | |||||||||
| Degree Granting Year | ||||||||||
| Description Type | Other | |||||||||
| Description | 2020年度 | |||||||||
| Language | ja | |||||||||
| Degree Granting Date | ||||||||||
| Date Granted | 2021-03-20 | |||||||||
| Degree Number | ||||||||||
| Dissertation Number | 甲第2397号 | |||||||||
| Right | ||||||||||
| Language | en | |||||||||
| Rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Modern Rheumatology following peer review. The version of record Nakamura Y, Fukutomi Y, Sekiya K, Kajiwara K, Kawasaki Y, Fujita N, Nagayama K, Iwata M, Iwamoto K, Yano K, Hamada Y, Watai K, Ryu K, Hayashi H, Kamide Y, Taniguchi M. Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis.Mod Rheumatol. 2022 Feb 28;32(2):387-395. is available online at : https://doi.org/ 10.1093/mr/roab005. | |||||||||
| Related Sites | ||||||||||
| Relation Type | isVersionOf | |||||||||
| Identifier Type | DOI | |||||||||
| Related Identifier | https://doi.org/10.1093/mr/roab005 | |||||||||
| 著者版フラグ | ||||||||||
| Version Type | AM | |||||||||
| Version Type Resource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||||||
